Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography

Positron emission tomography (PET) represents a unique molecular tool to get in vivo access to a wide spectrum of biological and neuropathological processes, of crucial relevance for neurodegenerative conditions. Although most PET findings are based on massive univariate approaches, in the last decade the increasing interest in multivariate methods has paved the way to the assessment of unexplored cerebral features, spanning from resting state brain networks to whole-brain connectome properties. Currently, the combination of molecular neuroimaging techniques with multivariate connectivity methods represents one of the most powerful, yet still emerging, approach to achieve novel insights into the pathophysiology of neurodegenerative diseases. In this review, we will summarize the available evidence in the field of PET molecular connectivity, with the aim to provide an overview of how these studies may increase the understanding of the pathogenesis of neurodegenerative diseases, over and above “traditional” structural/functional connectivity studies. Considering the available evidence, a major focus will be represented by molecular connectivity studies using [18F]FDG–PET, today applied in the major neuropathological spectra, from amyloidopathies and tauopathies to synucleinopathies and beyond. Pioneering studies using PET tracers targeting brain neuropathology and neurotransmission systems for connectivity studies will be discussed, their strengths and limitations highlighted with reference to both applied methodology and results interpretation. The most common methods for molecular connectivity assessment will be reviewed, with particular emphasis on the available strategies to investigate molecular connectivity at the single-subject level, of potential relevance for not only research but also diagnostic purposes. Finally, we will highlight possible future perspectives in the field, with reference in particular to newly available PET tracers, which will expand the application of molecular connectivity to new, exciting, unforeseen possibilities.

[1]  Jing Li,et al.  Learning brain connectivity of Alzheimer's disease by sparse inverse covariance estimation , 2010, NeuroImage.

[2]  W. Seeley Mapping Neurodegenerative Disease Onset and Progression. , 2017, Cold Spring Harbor perspectives in biology.

[3]  Johannes C. Klein,et al.  Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo , 2010, Neurology.

[4]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[5]  Karl Herholz,et al.  In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease , 2004, NeuroImage.

[6]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[7]  D. Perani,et al.  Unfavourable gender effect of high body mass index on brain metabolism and connectivity , 2018, Scientific Reports.

[8]  N. Volkow,et al.  Dynamic brain glucose metabolism identifies anti-correlated cortical-cerebellar networks at rest , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  Elisabetta Coppi,et al.  Brain changes within the visuo-spatial attentional network in posterior cortical atrophy. , 2014, Journal of Alzheimer's disease : JAD.

[10]  J. Trojanowski,et al.  Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain , 2017, The Journal of Neuroscience.

[11]  Luca Presotto,et al.  Gender differences in healthy aging and Alzheimer's Dementia: A 18F‐FDG‐PET study of brain and cognitive reserve , 2017, Human brain mapping.

[12]  A. Nordberg,et al.  Tau PET imaging: present and future directions , 2017, Molecular Neurodegeneration.

[13]  B. Biswal,et al.  Functional connectivity in the motor cortex of resting human brain using echo‐planar mri , 1995, Magnetic resonance in medicine.

[14]  B. Miller,et al.  Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.

[15]  Sang Won Seo,et al.  Functional connectivity associated with tau levels in ageing, Alzheimer’s, and small vessel disease , 2019, Brain : a journal of neurology.

[16]  Karl Herholz,et al.  Metabolic regional and network changes in Alzheimer's disease subtypes , 2018, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  Zeshan Ahmed,et al.  A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity , 2014, Acta Neuropathologica.

[18]  Lin Xie,et al.  Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology , 2014, The Journal of Nuclear Medicine.

[19]  Martin Hallbeck,et al.  Spreading of amyloid-β peptides via neuritic cell-to-cell transfer is dependent on insufficient cellular clearance , 2014, Neurobiology of Disease.

[20]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[21]  Martin Biermann,et al.  Default‐mode network functional connectivity is closely related to metabolic activity , 2015, Human brain mapping.

[22]  Takashi Asada,et al.  [Diagnosis of mild cognitive impairment]. , 2004, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica.

[23]  G. Frisoni,et al.  Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project , 2012, Neurobiology of Aging.

[24]  H. Kolb,et al.  [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease , 2013, Alzheimer's & Dementia.

[25]  D. Perani,et al.  A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting. , 2017, Journal of Alzheimer's disease : JAD.

[26]  J. Petrella,et al.  The Alzheimer structural connectome: changes in cortical network topology with increased amyloid plaque burden. , 2014, Radiology.

[27]  C. J. Gauthier,et al.  BOLD signal physiology: Models and applications , 2019, NeuroImage.

[28]  Claus Svarer,et al.  Covariance statistics and network analysis of brain PET imaging studies , 2019, Scientific Reports.

[29]  D. Perani,et al.  Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease , 2017, NeuroImage: Clinical.

[30]  Alessandra Bertoldo,et al.  [11C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis. , 2012, Journal of Alzheimer's disease : JAD.

[31]  Jiehui Jiang,et al.  Study of amyloid-β peptide functional brain networks in AD, MCI and HC. , 2015, Bio-medical materials and engineering.

[32]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[33]  Stephen M. Smith,et al.  Investigations into resting-state connectivity using independent component analysis , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[34]  Olaf Sporns,et al.  The Human Connectome: A Structural Description of the Human Brain , 2005, PLoS Comput. Biol..

[35]  Timo Grimmer,et al.  Metabolic connectivity for differential diagnosis of dementing disorders , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  S. Cappa,et al.  Brain connectivity in neurodegenerative diseases—from phenotype to proteinopathy , 2014, Nature Reviews Neurology.

[37]  V. Calhoun,et al.  Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging , 2017, Molecular Imaging and Biology.

[38]  C. Halldin,et al.  Molecular Imaging of the Dopamine Transporter , 2010, The Journal of Nuclear Medicine.

[39]  Chris C. Tang,et al.  A disease-specific metabolic brain network associated with corticobasal degeneration. , 2014, Brain : a journal of neurology.

[40]  A. Eusebio,et al.  Brain PET substrate of impulse control disorders in Parkinson's disease: A metabolic connectivity study , 2018, Human brain mapping.

[41]  D. Perani,et al.  Evaluation of an optimized [18F]fluoro‐deoxy‐glucose positron emission tomography voxel‐wise method to early support differential diagnosis in atypical Parkinsonian disorders , 2017, European journal of neurology.

[42]  A. Raj,et al.  Analysis of Amyloid-β Pathology Spread in Mouse Models Suggests Spread Is Driven by Spatial Proximity, Not Connectivity , 2017, Front. Neurol..

[43]  Martijn P. van den Heuvel,et al.  Simulating disease propagation across white matter connectome reveals anatomical substrate for neuropathology staging in amyotrophic lateral sclerosis , 2016, NeuroImage.

[44]  Jubin Abutalebi,et al.  The impact of bilingualism on brain reserve and metabolic connectivity in Alzheimer's dementia , 2017, Proceedings of the National Academy of Sciences.

[45]  D. Wilson Tissue , 2009, The Lancet.

[46]  J. Winderickx,et al.  Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies , 2014, Acta neuropathologica communications.

[47]  O. Raitakari,et al.  Mapping neurotransmitter networks with PET: An example on serotonin and opioid systems , 2014, Human brain mapping.

[48]  Jongbum Seo,et al.  Connectivity analysis of normal and mild cognitive impairment patients based on FDG and PiB-PET images , 2015, Neuroscience Research.

[49]  Nick C. Fox,et al.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging and Alzheimer's Association workgroup , 2011 .

[50]  D. Perani,et al.  The emerging role of PET imaging in dementia , 2017, F1000Research.

[51]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[52]  D. Perani FDG-PET and amyloid-PET imaging: the diverging paths. , 2014, Current opinion in neurology.

[53]  B Horwitz,et al.  Intercorrelations of Glucose Metabolic Rates between Brain Regions: Application to Healthy Males in a State of Reduced Sensory Input , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[54]  Zhuangzhi Yan,et al.  Differences in Aβ brain networks in Alzheimer's disease and healthy controls , 2017, Brain Research.

[55]  Noo Li Jeon,et al.  β‐Amyloid is transmitted via neuronal connections along axonal membranes , 2014, Annals of neurology.

[56]  Alessandro Giuliani,et al.  Progressive Disintegration of Brain Networking from Normal Aging to Alzheimer Disease: Analysis of Independent Components of 18F-FDG PET Data , 2017, The Journal of Nuclear Medicine.

[57]  C. Grady,et al.  Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease , 1987, Brain Research.

[58]  Yong He,et al.  BrainNet Viewer: A Network Visualization Tool for Human Brain Connectomics , 2013, PloS one.

[59]  D. Spencer,et al.  Imaging synaptic density in the living human brain , 2016, Science Translational Medicine.

[60]  E. Fransén,et al.  PET studies of D2‐receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans , 2010, Synapse.

[61]  M. Breakspear,et al.  The connectomics of brain disorders , 2015, Nature Reviews Neuroscience.

[62]  Thomas T. Liu,et al.  Neurovascular factors in resting-state functional MRI , 2013, NeuroImage.

[63]  E. Croteau,et al.  Inverse relationship between brain glucose and ketone metabolism in adults during short-term moderate dietary ketosis: A dual tracer quantitative positron emission tomography study , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[64]  D. Perani,et al.  Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria , 2019, Alzheimer's Research & Therapy.

[65]  B. Borroni,et al.  Impulse control disorder in PD: A lateralized monoaminergic frontostriatal disconnection syndrome? , 2016, Parkinsonism & related disorders.

[66]  Christine DeLorenzo,et al.  Molecular connectivity disruptions in males with major depressive disorder , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[67]  Igor Yakushev,et al.  Metabolic connectivity: methods and applications , 2017, Current opinion in neurology.

[68]  Nick C Fox,et al.  Molecular nexopathies: a new paradigm of neurodegenerative disease , 2013, Trends in Neurosciences.

[69]  W. Jagust Imaging the evolution and pathophysiology of Alzheimer disease , 2018, Nature Reviews Neuroscience.

[70]  C. Rowe,et al.  In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer. , 2012, Nuclear medicine and biology.

[71]  C. Rowe,et al.  Divergent Network Patterns of Amyloid-β Deposition in Logopenic and Amnestic Alzheimer's Disease Presentations. , 2016, Biological psychiatry. Cognitive neuroscience and neuroimaging.

[72]  N. Koglin,et al.  New protein deposition tracers in the pipeline , 2016, EJNMMI Radiopharmacy and Chemistry.

[73]  O. Sporns,et al.  Complex brain networks: graph theoretical analysis of structural and functional systems , 2009, Nature Reviews Neuroscience.

[74]  E. Croteau,et al.  A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease , 2017, Experimental Gerontology.

[75]  G L Shulman,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .

[76]  W. Klunk,et al.  Small-molecule PET Tracers for Imaging Proteinopathies. , 2017, Seminars in nuclear medicine.

[77]  C. Jack,et al.  NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.

[78]  Daniel R. Schonhaut,et al.  PET Imaging of Tau Deposition in the Aging Human Brain , 2016, Neuron.

[79]  Adriano Chiò,et al.  Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis , 2014, Neurology.

[80]  L. Mucke,et al.  A network dysfunction perspective on neurodegenerative diseases , 2006, Nature.

[81]  Murray Grossman,et al.  Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis , 2013, Annals of neurology.

[82]  A. Stoessl,et al.  Glucose Use Correlations: A Matter of Inference , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[83]  Andreas Hahn,et al.  Making Sense of Connectivity , 2018, The international journal of neuropsychopharmacology.

[84]  Kazuhiko Yanai,et al.  18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease. , 2011, Brain : a journal of neurology.

[85]  J. Trojanowski,et al.  Spreading of pathology in neurodegenerative diseases: a focus on human studies , 2015, Nature Reviews Neuroscience.

[86]  Alex Becker,et al.  In vivo characterization of the early states of the amyloid-beta network. , 2013, Brain : a journal of neurology.

[87]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[88]  Maria Luisa Gorno-Tempini,et al.  Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease , 2016, Human brain mapping.

[89]  K. Whittingstall,et al.  A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment , 2019, Alzheimer's & Dementia.

[90]  Bharat B. Biswal,et al.  Do all roads lead to Rome? A comparison of brain networks derived from inter-subject volumetric and metabolic covariance and moment-to-moment hemodynamic correlations in old individuals , 2017, Brain Structure and Function.

[91]  Kazuhiko Yanai,et al.  18 F-THK 523 : a novel in vivo tau imaging ligand for Alzheimer ’ s disease , 2011 .

[92]  A. Joshi,et al.  Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. , 2016, Brain : a journal of neurology.

[93]  Nick C Fox,et al.  The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .

[94]  Luca Presotto,et al.  Metabolic connectomics targeting brain pathology in dementia with Lewy bodies , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[95]  V. Calhoun,et al.  Resting-State Networks as Simultaneously Measured with Functional MRI and PET , 2017, The Journal of Nuclear Medicine.

[96]  Ji Hyun Ko,et al.  Metabolic resting-state brain networks in health and disease , 2015, Proceedings of the National Academy of Sciences.

[97]  Annalena Venneri,et al.  Review: Parkinson's disease: from synaptic loss to connectome dysfunction , 2016, Neuropathology and applied neurobiology.

[98]  Bharat B. Biswal,et al.  Metabolic Brain Covariant Networks as Revealed by FDG-PET with Reference to Resting-State fMRI Networks , 2012, Brain Connect..

[99]  Gereon R Fink,et al.  NETWORKS OF TAU DISTRIBUTION IN ALZHEIMER’S DISEASE , 2017, Alzheimer's & Dementia.

[100]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[101]  Efstathios D. Gennatas,et al.  Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome , 2012, Neuron.

[102]  Edward T. Bullmore,et al.  Connectomics: A new paradigm for understanding brain disease , 2015, European Neuropsychopharmacology.

[103]  Thomas E. Nichols,et al.  Functional connectomics from resting-state fMRI , 2013, Trends in Cognitive Sciences.

[104]  Matti Laine,et al.  The Learning Brain , 2000, Brain and Language.

[105]  Eric Guedj,et al.  Metabolic Networks Underlying Cognitive Reserve in Prodromal Alzheimer Disease: A European Alzheimer Disease Consortium Project , 2013, The Journal of Nuclear Medicine.

[106]  Karl J. Friston,et al.  Local Activity Determines Functional Connectivity in the Resting Human Brain: A Simultaneous FDG-PET/fMRI Study , 2014, The Journal of Neuroscience.

[107]  Karl J. Friston,et al.  Metabolic connectivity mapping reveals effective connectivity in the resting human brain , 2015, Proceedings of the National Academy of Sciences.

[108]  A. Frick,et al.  Quantitative positron emission tomography in brain research , 2017, Brain Research.

[109]  E. Westman,et al.  Amyloid Network Topology Characterizes the Progression of Alzheimer’s Disease During the Predementia Stages , 2017, Cerebral cortex.

[110]  P. Svenningsson,et al.  Nigrostriatal dopamine transporter availability in early Parkinson's disease , 2018, Movement disorders : official journal of the Movement Disorder Society.

[111]  B. Miller,et al.  Classification of primary progressive aphasia and its variants , 2011, Neurology.

[112]  M. Cabrera-Martín,et al.  Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[113]  Alan J. Thomas,et al.  Diagnosis and management of dementia with Lewy bodies , 2017, Neurology.

[114]  Paul Edison Brain Connectivity in Neurodegenerative Diseases , 2020, Brain Connect..

[115]  Luigi Gianolli,et al.  Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting , 2014, NeuroImage: Clinical.

[116]  Chris C. Tang,et al.  Dopaminergic correlates of metabolic network activity in Parkinson's disease , 2015, Human brain mapping.

[117]  John Seibyl,et al.  Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study , 2015, Alzheimer's & Dementia.

[118]  A Jon Stoessl,et al.  Glucose utilization: still in the synapse , 2017, Nature Neuroscience.

[119]  Nick C Fox,et al.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria , 2014, The Lancet Neurology.

[120]  Agneta Nordberg,et al.  Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue. , 2013, Brain : a journal of neurology.

[121]  Jae Sung Lee,et al.  Metabolic connectivity by interregional correlation analysis using statistical parametric mapping (SPM) and FDG brain PET; methodological development and patterns of metabolic connectivity in adults , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[122]  D. Perani,et al.  The brain metabolic signature of visual hallucinations in dementia with Lewy bodies , 2018, Cortex.

[123]  Luca Presotto,et al.  Altered brain metabolic connectivity at multiscale level in early Parkinson’s disease , 2017, Scientific Reports.

[124]  Pia Baldinger,et al.  Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression , 2014, Human brain mapping.

[125]  D. Perani,et al.  Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[126]  Konstantinos Chiotis,et al.  Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding , 2018, Alzheimer's & dementia.

[127]  Matthias S. Müller,et al.  The Emerging Role of , 2004 .

[128]  Nick C Fox,et al.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.

[129]  D. Perani,et al.  Different FDG-PET metabolic patterns at single-subject level in the behavioral variant of fronto-temporal dementia , 2016, Cortex.

[130]  D. Na Diagnosis and management of dementia. , 1997 .

[131]  Mark Hallett,et al.  Criteria for the diagnosis of corticobasal degeneration , 2013, Neurology.

[132]  P. Dupont,et al.  Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease☆ , 2013, NeuroImage: Clinical.

[133]  Vinod Menon,et al.  Functional connectivity in the resting brain: A network analysis of the default mode hypothesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.